Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8975884rdf:typepubmed:Citationlld:pubmed
pubmed-article:8975884lifeskim:mentionsumls-concept:C0128897lld:lifeskim
pubmed-article:8975884lifeskim:mentionsumls-concept:C0600431lld:lifeskim
pubmed-article:8975884lifeskim:mentionsumls-concept:C1372999lld:lifeskim
pubmed-article:8975884lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:8975884pubmed:issue6lld:pubmed
pubmed-article:8975884pubmed:dateCreated1997-1-22lld:pubmed
pubmed-article:8975884pubmed:abstractTextMonocyte chemoattractant protein-1 (MCP-1) is a member of the Cys-Cys chemokine family. Two related MCP-1 receptors have been identified (CC-CKR2A and CC-CKR2B), although the precise kinetics of ligand binding and calcium signaling of these receptors has yet to be investigated. To examine this more closely, the human MCP-1 receptors were cloned and expressed in Chinese hamster ovary (CHO) cells. Membranes prepared from cells expressing CC-CKR2B bind MCP-1 selectively and with high affinity (Kd = 120 pM). MCP-1 stimulation of recombinant CHO cells expressing CC-CKR2B induces a rapid increase in intracellular Ca2+ through both receptor-operated Ca2+ channels and mobilization of Ca2+ from intracellular stores, and leads to a rapid temperature-dependent internalization of the ligand/receptor complexes. In contrast, recombinant CHO cells expressing CC-CKR2A, and membranes prepared from these cells, fail to bind detectable levels of MCP-1. However, MCP-1 stimulation of cells expressing CC-CKR2A induces a small but significant increase in intracellular Ca2+. Repeated stimulation of these cells with MCP-1 leads to a potentiation of the response to a level comparable to that seen in cells expressing CC-CKR2B. These observations suggest that the levels of cell surface CC-CKR2A are controlled by novel mechanisms.lld:pubmed
pubmed-article:8975884pubmed:languageenglld:pubmed
pubmed-article:8975884pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:citationSubsetIMlld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8975884pubmed:statusMEDLINElld:pubmed
pubmed-article:8975884pubmed:monthDeclld:pubmed
pubmed-article:8975884pubmed:issn0741-5400lld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:GreerMMlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:WilsonRRlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:AndersonMMlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:MartinLLlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:ReillyCClld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:HollisMMlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:BarrattDDlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:NeedhamMMlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:CerilloGGlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:WarburtonHHlld:pubmed
pubmed-article:8975884pubmed:authorpubmed-author:SturgessNNlld:pubmed
pubmed-article:8975884pubmed:issnTypePrintlld:pubmed
pubmed-article:8975884pubmed:volume60lld:pubmed
pubmed-article:8975884pubmed:ownerNLMlld:pubmed
pubmed-article:8975884pubmed:authorsCompleteYlld:pubmed
pubmed-article:8975884pubmed:pagination793-803lld:pubmed
pubmed-article:8975884pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:meshHeadingpubmed-meshheading:8975884-...lld:pubmed
pubmed-article:8975884pubmed:year1996lld:pubmed
pubmed-article:8975884pubmed:articleTitleMonocyte chemoattractant protein-1: receptor interactions and calcium signaling mechanisms.lld:pubmed
pubmed-article:8975884pubmed:affiliationCardiovascular & Musculoskeletal Research Department, ZENECA Pharmaceuticals, Mereside, Cheshire, United Kingdom.lld:pubmed
pubmed-article:8975884pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8975884lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8975884lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8975884lld:pubmed